You're viewing a public preview of this transaction Sign up free to access full investor details, deal amounts & seller data
Sign Up Free Log In
Deal Overview

SCA Pharmaceuticals (Secondary Buyout, in 2021)

Transaction #135396
Investors
2
Sign up to view
Target Company
SCA Pharmaceuticals
Life Science · United States
Seller
1
Sign up to view
21 Jan 2021
Announced
Target Company
Company Sector Entity Type Status State Country
SCA Pharmaceuticals Life Science Private Active Arkansas (AR) United States
Investors 2
InvestorInvestment TypeAmount% Holding
View 2 Investors
Sign up to access investor names, investment types, deal amounts and ownership percentages
Sign Up Free Log In
Sellers 1
Seller
View 1 Seller
Sign up free to access seller names and full exit details for this transaction
Sign Up Free Log In
Frequently Asked Questions
What is the SCA Pharmaceuticals acquisition deal?
This transaction is an acquisition of SCA Pharmaceuticals (Secondary Buyout) in 2021. The target company operates in the Life Science sector. Full deal details are available on AcquityData.
When did the SCA Pharmaceuticals acquisition happen?
This transaction was announced on 21 Jan 2021.
What is the deal value of the SCA Pharmaceuticals acquisition?
Deal value information for this transaction is available on AcquityData.
Who are the investors in the SCA Pharmaceuticals transaction?
This transaction has 2 investors. Sign up to AcquityData to view investor names, investment types, amounts and ownership details.

Access the full SCA Pharmaceuticals deal profile

Unlock investor names, amounts, seller details and complete M&A intelligence in one connected platform.

Start Free Trial